Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Goodwin

Showing results (411-420 of 416) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 416 results.
Oncogene|September 12, 2017
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivoD F Comiskey, A G Jacob, B L Sanford, et al.
Science (New York, N.Y.)|January 24, 2004
Brightening depressionAnna Wirz-Justice, Michael Terman, Dan A Oren, et al.
Metabolism: Clinical and Experimental|February 18, 2006
Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenaseEduard A Struys, Nanda M Verhoeven, Erwin E W Jansen, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studiesAlan J Gelenberg, Michael E Thase, Roger E Meyer, et al.
The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
Pageof 42

Showing results (411-420 of 416) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 416 results.
Oncogene|September 12, 2017
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivoD F Comiskey, A G Jacob, B L Sanford, et al.
Science (New York, N.Y.)|January 24, 2004
Brightening depressionAnna Wirz-Justice, Michael Terman, Dan A Oren, et al.
Metabolism: Clinical and Experimental|February 18, 2006
Metabolism of gamma-hydroxybutyrate to d-2-hydroxyglutarate in mammals: further evidence for d-2-hydroxyglutarate transhydrogenaseEduard A Struys, Nanda M Verhoeven, Erwin E W Jansen, et al.
The Journal of Clinical Psychiatry|February 5, 2009
The history and current state of antidepressant clinical trial design: a call to action for proof-of-concept studiesAlan J Gelenberg, Michael E Thase, Roger E Meyer, et al.
The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
Pageof 42